La valutazione degli stati di salute sulla base delle preferenze ...

More documents

Recommendations

Info

Bleichrodt, H. (2002) – "A New Explanation for the Difference Between SG and TTO Utilities."Health Economics, 11, 447-456.Bleichrodt H., Pinto J.L. (2002) “A New Type of Preference Reversal”, mimeo, ErasmusUniversity.Bleichrodt H., Pinto J.L. (2002a) – “Loss aversion and scale compatibility in two-attribute tradeoffs”,Journal of Mathematical Psychology, 46, 315-337.Bleichrodt H., Pinto J.L., Abellan-Perpinan J.M. (2002) – “A Consistency Test of the Time Tradeoff”,mimeo, Erasmus University.Boyle M. H., Torrance G. W e Sinclair J.C. (1983) – “Economic evaluation of neonatal intensivecare of very-low-birth-weight infants”, New England Journal of Medicine, 308, 1330-1337.Bush, J.W., Chen, M. e Patrick, D.L. (1973) – “Cost-effectiveness Using a Health Status Index:Analysis of the New York State PKU Screening Program”, Health Status Indexes a cura di Berg.R., Chicago: Hospital Research and Educational Trust.Culyer A.J. e Wagstaff A. (1993) – “QALYs versus HYEs”, Journal of Health Economics, 11, 311-323.Devlin N.J., Hansen P., Kind P. e A.Williams (2003) – “Logical inconsistencies in surveyrespondents’ health state valuations – a methodological challenge for estimating social tariffs”,Health Economics, 12, 529-544.Dolan (1996) – “The effect of experience of illness on health state valuations”, Journal of ClinicalEpidemiology, 49, 551-564.Dolan P., Kind P. (1996) – “Inconsistency and health state valuations”; Social Science andMedicine, 42, 609-615.Dolan P., Gudex, C., Kind, P., Williams A. (1996) – “The time trade-off method: results from aGeneral Population Study”, Health Economics, 5, 141-154.Dolan P., Jones-Lee M. (1997) –“The time trade-off : a note on the effect of lifetime reallocation ofconsumption and discounting”, Journal of Health Economics, 16, 731-739.Dolan P., Roberts J. (2002) – “To what extent can we explain time trade-off values from otherinformation about respondents?”, Social Science and Medicine, 54, 919-929.Dolan P., Sutton M. (1997) – “Mapping visual analogue scale health state onto standard gambleand time trade-off values”, Social Science and Medicine, 44, 1519-1530.Drummond M.F., Stoddart, Torrance G.W. (1987) –Methods for Economic Evaluation of HealthCare Programmes, Oxford University Press, Oxford.Drummond M.F., Heyse J., Cooke J., McGuire A. (1993) – “A selection of end-points in economicevaluations of coronary-heart disease interventions”, Medical Decision Making, 13, 184-90.Drummond M.F., O’Brien B., Stoddart G.L. e t Torrance G.W. (1997) – Methods for EconomicEvaluation of Health Care Programmes, Oxford University Press, Oxford.Dyer J.S. e Sarin R.K. (1982) – “Relative risk aversion”, Management Science, 28 (8), 875-886.Furlong W., Feeny D., Torrance G., Barr R., Horsman J. (1990) – Guide to design and developmentof health state utility instrumentation, Hamilton, Canada, McMaster University.Gafni A. (1994) – “The standard gamble method: what is being measured and how it is interpreted”,Health Service Review, 29, 207-224.Gafni A. e Birch S. (1993) –”Economics, health and health economics: HYEs versus QALYs”,Journal of Health Economics, 11, 325-339.28
Gafni A., Birch S. (1995) – “Preference for outcomes in economic evaluation: an economicapproach to solving economic problems“, Social Science and Medicine, 40, 767-776.Gafni A. and Torrance G.W. (1984) – “Risk Attitude and Time-preference in Health”, ManagementScience, 30, 440-451.Grenn C., Brazier J. e Deverill M. (2000) – “Valuing health-related qualità of life: a review ofhealth state valueation techniques”, PharmacoEconomics, 17(2), 151-165.Grether D. e Plott C. (1979) – “Economic theory of choice and the Preference Reversalphenomenon, American Economic Review, 69.Groot W. (2000) “Adaptation and scale of reference bias in self-assessments of quality of life”,Journal of Health Economics, 19, 403-420.Hornberger J.C., Redelmeier D.A. and Peterson J. (1992) –“Variability among methods to assesspatients’ well being and consequent effect on a cost-effectiveness analysis“, Journal of ClinicalEpidemiology, 45, 505-512.Johannesson M., Plinskin J. e Weinstein M. (1993) – “Are healthy-years equivalents animprovement over quality-adjusted life years?”, Medical Decision Making, 13(4), 281-286.Jones-Lee M., Loomes G., O’Reilly D., e Philips P. (1993) –The value of preventing non fatal roadinjuries, Transport Research Laboratory, Department of Transport, UK.Kahneman D. e A. Tversky (1979) – “Prospect Theory: an analysis of decision under risk”,Econometrica, 47, 263-291.Kahneman D. e A. Tversky (1981) –“ The framing of decisions and the psychology of choice“,Science, 211, 453-460Klarman, H.E., Francis, J.O.S., Rosental, G., (1968) – “Cost-Effectiveness Analysis Applied to theTreatment of Chronic Renal Disease”, Medical Care, 6(1), 48-54.Lalonde L., Clarke A.E. et al. (1999) – “Comparing the Psychometric properties of preferencebasedand non-preference-based health-related quality of life in coronary heart disease”, QualityLife Research, 8, 399-409.Lalonde L., Clarke A.E. et al. (2001) – “Health related quality of life with coronary heart diseaseprevention and treatment”, Journal of Clinical Epidemiology, 54, 1011-1018.Lewis E.F., Johnson P.A. et al. (2001) – “Preference for Quality of Life or Survival Expressed byPatients with Heart Failure”, Journal of Heart and Lung Transplantation, 20,1016-1024.Lichtenstein S. e Slovic P. (1971) – “Reversals of preference between bids and choices in gamblingdecisions“, Journal of Experimental Psychology, 89, 46-55.Loomes G. e McKenzie L. (1989) – “The use of QALYs in health care decision making”, SocialScience and Medicine, 28, 299-308.Mehrez A. e Gafni A. (1989) – “Quality adjusted life years, utility theory, and healthy-yearsequivalents”, Medical Decision Making, 9, 142-149.Mehrez A. e Gafni A. (1991) – “The healthy-years equivalents: how to measure them using thestandard method approach”, Medical Decision Making, 11, 140-146.Mehrez A. e Gafni A. (1993) – “The healthy-years equivalents versus quality-adjusted life years: inpursuit of progress”, Medical Decision Making, 13, 287-292.29
Page 2 and 3: INTRODUZIONEStabilire delle priorit
Page 4 and 5: dati. Anche se l’esclusione degli
Page 6 and 7: Nel caso di valutazione di stati di
Page 8 and 9: dichiara indifferente tra le due al
Page 10 and 11: In effetti, numerosi studi empirici
Page 12 and 13: degli stati di salute ha due attrib
Page 14 and 15: incoerente se uno stato di salute l
Page 16 and 17: occorrerebbe tuttavia effettuare un
Page 18 and 19: L’obiettivo della parte centrale
Page 20 and 21: genera valori dell’utilità pross
Page 22 and 23: In letteratura, non esiste omogenei
Page 24 and 25: piccola rispetto a NO-CARD, quindi
Page 26 and 27: In questo lavoro abbiamo analizzato
Page 30 and 31: Ohinmaa A. e Sintonen H. (1999) -
Page 32 and 33: Tabella 1 - Differenze tra metodi d
Page 34 and 35: Tabella 3 - Variabili descrittive d
Page 36 and 37: Tabella 5 - Graduatoria delle tre t
Page 38 and 39: Tabella 7 - Effetti delle caratteri
Page 40: Tabella b - Confronto di omogeneit

La valutazione degli stati di salute sulla base delle preferenze ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?